A first evaluation of the efficacy of minibeam radiation therapy combined with an immune check point inhibitor in a model of glioma-bearing rats
Glioblastoma multiforme (GBM) continues to be a hopeless case today.Its treatment involves the use of multiple modalities.One of them is radiation therapy (RT), that is limited by normal tissue tolerances in GBM patients.GBM is widely recognized to induce local and systemic immunosuppression, which is a hindrance to the use of immune-modulating the